The high-affinity CXCR4 antagonist BKT140 is safe and induces a robust mobilization of human CD34+ cells in patients with multiple myeloma (Q39061801)
Jump to navigation
Jump to search
scientific article published on 18 November 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | The high-affinity CXCR4 antagonist BKT140 is safe and induces a robust mobilization of human CD34+ cells in patients with multiple myeloma |
scientific article published on 18 November 2013 |
Statements
1 reference
The high-affinity CXCR4 antagonist BKT140 is safe and induces a robust mobilization of human CD34+ cells in patients with multiple myeloma (English)
1 reference
Irit Avivi
1 reference
Izhar Hardan
1 reference
Arnon Nagler
1 reference
Avichai Shimoni
1 reference
Amnon Peled
1 reference
Michal Abraham
1 reference
Jacob M Rowe
1 reference
Katia Beider
1 reference
Hanna Wald
1 reference
Lena Tiomkin
1 reference
Lena Ribakovsky
1 reference
Yossi Riback
1 reference
Yaron Ramati
1 reference
Sigal Aviel
1 reference
Howard Laurence Shaw
1 reference
Orly Eizenberg
1 reference
18 November 2013
1 reference
1 reference
20
1 reference
2
1 reference
469-479
1 reference
Identifiers
1 reference
1 reference